Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v41-FR Version v25-FR
Language French French
Date Updated 2019-05-02 2018-05-07
Drug Identification Number 02457431 02457431
Brand name ERFA-TRANEXAMIC ERFA-TRANEXAMIC
Common or Proper name TRANEXAMIC ACID IV TRANEXAMIC ACID IV
Company Name ERFA CANADA 2012 INC ERFA CANADA 2012 INC
Ingredients TRANEXAMIC ACID TRANEXAMIC ACID
Strength(s) 100 mg/mL 100 mg/mL
Dosage form(s) Solution Solution
Route of administration Intravenous Intravenous
Packaging size vial vial
ATC code B02AA B02AA
ATC description Antifibrinolytics Antifibrinolytics
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2018-04-25 2018-04-25
Estimated end date 2019-06-21 2018-07-02
Actual end date
Shortage status Actual shortage Actual shortage
Company comments 5ML VIAL AVAILABLE - 10ML TO BE AVAILABLE END OF MAY - 50 ML TO BE AVAILABLE IN JUNE FYI- Erfa Tranexamic acid 50 ml -1 vial of 50 ml to be available in July 2018 and 10x 5 mL to be (pack of 10 vials of 5 ml )available in June 2018 due to product recall.
Health Canada comments